Delivery Order SPE2DB22D6029-SPE2DB24FLTFL

Award Date 9/19/24
Potential Completion Date 9/20/24
Potential Value $1.5K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $7,643.96 Firm Fixed Price Delivery Order covers the supply of 100 units of RYTARY ER 23.75 MG-95 MG capsules. The contract has an ultimate completion date of January 17, 2023 and was awarded on January 13, 2023. This award is associated with a larger Indefinite Delivery Contract (IDC) that AmerisourceBergen holds...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the delivery of RYTARY ER 48.75 MG-195 MG capsules. The contract has a ceiling value of $4,484.13 and a completion date of September 23, 2024. It is a Firm Fixed Price Delivery Order contract, with no set-aside designation. Amerisourcebergen is the prime contractor, and the contract is associated with a larger Indefinite Delivery Contract (IDC)...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $28,861.84 firm fixed-price delivery order is for the medication RYTARY ER 36.25 MG-145 MG capsules. The contract has an ultimate completion date of December 11, 2024. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for...
This federal contract award is for the delivery of RYTARY ER 48.75 MG-195 MG capsules to the Defense Logistics Agency (DLA). The contract was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract has a ceiling value of $3,985.82 and a completion date of February 9, 2023. This is a delivery order under a larger Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA Troop Support Medical, valued at $999,999,999...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $5,560.96 firm fixed-price delivery order is for the supply of RYTARY ER 23.75 MG-95 MG capsules. The award is part of a larger Indefinite Delivery Contract (IDC) between AmerisourceBergen and the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. This IDC serves as a primary...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $44,401.68, is for the delivery of RYTARY ER 36.25 MG-145 MG capsules and has a completion date of September 20, 2023. The contract is a firm fixed-price delivery order with no set-aside designation, indicating open competition. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC)...
This federal contract award was made by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $3,966.05, is for the delivery of RYTARY ER 48.75 MG-195 MG capsules. The award is a firm fixed-price delivery order under a larger Indefinite Delivery Contract (IDC) held by Amerisourcebergen's parent company, Cencora, Inc., with the DLA Troop Support Medical. This IDC, valued at up to...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award, valued at $12,527.63, is a delivery order contract for the pharmaceutical product RYTARY ER 36.25 MG-145 MG capsules. The contract has a firm fixed price pricing type and runs through February 4, 2025. This award is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the delivery of RYTARY ER 48.75 MG-195 MG capsules. The $2,988.37 firm fixed-price delivery order has a completion date of March 11, 2024. The award was not designated under any set-aside program. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for...
The federal contract award is for the delivery of RYTARY ER 36.25 MG-145 MG CAP 100S pharmaceutical products to the Defense Logistics Agency (DLA) Troop Support Medical. The $15,796.42 firm-fixed-price delivery order was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, with a completion date of September 3, 2024. This award is part of a larger Indefinite Delivery Contract (IDC) between Amerisourcebergen and the DLA Troop Support Medical, valued at up to $999,999,999,...
  • SPE2DB22D6029
    Indefinite Delivery Contract
  • SPE2DB22D6029-SPE2DB24FLTFL
    Delivery Order

This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the delivery of RYTARY ER 48.75 MG-195 MG capsules. The $1,519.89 firm fixed-price delivery order contract has a completion date of September 20, 2024. This award is associated with a larger Indefinite Delivery Contract (IDC) between AmerisourceBergen and the DLA Troop Support Medical, valued up to $999,999,999 through December 2025, for the supply of a comprehensive range of medical commodities to support military treatment programs and facilities worldwide. The contract is not designated as a set-aside.

Generated 12/19/24, 9:28 AM